Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50 -2.78% 87.50 85.00 90.00 90.00 87.50 90.00 15,829 16:11:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.7 -9.1 -8.0 - 103

Shield Therapeutics Share Discussion Threads

Showing 5701 to 5723 of 6225 messages
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
DateSubjectAuthorDiscuss
30/4/2020
11:54
Perhaps chinese will come in knock out bid 275p.
montyhedge
30/4/2020
11:53
6 months ago I was topping up at this Level thinking I was definitely at the bottom ! Still away to go to levels we should be at imho. £2 min before news.
peachie 74
30/4/2020
11:46
Amazing rise today. Surely there must be something behind it. Bizarrely in the early hours this morning, I was thinking about why Carl Sterrit left so precipitately. Yes I know, I am sad! But to carry on my thought process, the dramatic rise since the initial plunge after the news came out, suggests to me some corporate shenanigans going on behind the scene. I think there was a fundamental disagreement about strategy and my bet is that they are now looking for a buyer of the whole company. Pure speculation but the conclusion I came to at 4 this morning!
nobbygnome
30/4/2020
11:28
Something its seems about to happen, always someone knows more than us, shareprices talk and this shouting news shortly.
montyhedge
30/4/2020
11:25
Bubbling up nicely - 119.90/128.10 (IG) Makes me wonder if CS was being obstinate ...
daveboy1
30/4/2020
11:24
Wonder why it's rising. Has there been a leak?
78steve
30/4/2020
11:24
We’re on board peachie lol for ages, certainly some usual activity, a few select investors must be hearing some pleasing news me thinks
ny boy
30/4/2020
10:27
Yep patience. If you’re holding ! This is running away atm if your not on board
peachie 74
30/4/2020
10:08
Onwards and upwards, stay safe - stay patient
ny boy
30/4/2020
10:06
Steve. The RNS did not make this go to 50. It was an accumulation of Covid scare Griffiths sold millions at a time of no real volume. Only way he could sell was taking the price so far down. He has sold fair amounts over lots of shares recently. The RNS about the H2H was an minor typo almost about inclusion data. Also it was only referencing GI patients. Shields product applies to all forms of iron deficiency. Edison maintained their 295 target after this. But DYOR mate. With ANY share you never know what’s around the corner. Otherwise we would all be millionaires !
peachie 74
30/4/2020
10:01
Those are the people that deserve to, and do miss the bus to the party. Top Asian pharma doesn't cough up millions up front on the basis of a flaky rns ...
daveboy1
30/4/2020
09:45
I think some people's confidence has been shaken due to recent rns that made it hit 50p makes you wonder what else will come to light. How do you tell if this is undervalued or not based on what i mean it's not based on actual sales numbers
78steve
30/4/2020
09:36
What a great chart....
nobbygnome
30/4/2020
09:24
Scary how quick this rises. Relatively small number of shares in PI hands. People going to be left behind here very quickly if this continues
peachie 74
30/4/2020
08:51
Off we go again. I’ve said it before , these IMO are cheap as chips. DYOR , but we have a derisked treatment for the worlds biggest deficiency. It can compete with IV iron which requires hospitalisation etc FDA BROAD label granted ASK paying multi millions to expand us into China and Hong Kong Patents for years The rest of the world to conquer !
peachie 74
29/4/2020
19:23
They’ve not reported that they’ve submitted for pricing in any market since the H2H was released. There was an analysis released which said it was cost effective I think. No doubt in my mind they would be and they should get pricing if Norgine pulled its fat finger out.
crankyman
29/4/2020
19:18
Here you go best. To make you feel better ! https://www.edisongroup.com/publication/aegis-2-update/26377/#
peachie 74
28/4/2020
18:52
There’s not been any prices negotiated based on that data
crankyman
27/4/2020
22:30
Lako.... discussed previous Cranky. Agree totally.
peachie 74
27/4/2020
21:59
Isn't there a potential issue here with Teva? Doesn't seem to be mentioned?
lako42
27/4/2020
21:16
Unlikely that H2H issue impacts sales. Very unlikely. But possibly the whole strategy required a reset or there might have been some misconduct we didn’t know about or both. Clearly with him staying to aid with the US deal closing I don’t see this as being really about US deal failures.
crankyman
27/4/2020
20:01
Know doubting the massive potential like NY boy I took a position in the mid high 30p we are where we are because things have gone on that we are not privy to at the moment and may never be. The fact that the founder had to step down tells you things have gone badly wrong with the USA negotiations and then we had the H2H fiasco which I’m amazed for something so uncomplicated as it appears we have still not had news on review and likely consequences on NordginesMarketing of the product. In my Opinion a USA deal is no where near we know Former CEO was handling the negotiations it would be extremely unlikely he would be given the boot at such a crucial stage I hope I’m wrong but that’s my gut feeling.It would be a catastrophe if the H2H was having a bearing on sales as we have the perfect circumstances to pinch share from IV. The one positive I see from the above is that a USA suitor may be frustrated and with the CEO gone through Large shareholder pressures we may get a takeover approach.
best1467
27/4/2020
10:47
I’m just amazed more people cannot see the huge potential here and aren’t taking the opportunity to get in at these levels
peachie 74
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
ADVFN Advertorial
Your Recent History
LSE
STX
Shield The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200711 21:39:45